These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


95 related items for PubMed ID: 1360085

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Absence of familial defective apolipoprotein B-100 in Japanese patients with familial hypercholesterolaemia.
    Nohara A, Yagi K, Inazu A, Kajinami K, Koizumi J, Mabuchi H.
    Lancet; 1995 Jun 03; 345(8962):1438. PubMed ID: 7760626
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Familial defective apolipoprotein B-100 in 12 subjects and their kindred.
    Geisel J, Schleifenbaum T, Oette K, Weisshaar B.
    Eur J Clin Chem Clin Biochem; 1992 Nov 03; 30(11):729-36. PubMed ID: 1489844
    [Abstract] [Full Text] [Related]

  • 5. Familial defective apolipoprotein B-100: a lesson from homozygous and heterozygous patients.
    Ceska R, Vrablík M, Horínek A.
    Physiol Res; 2000 Nov 03; 49 Suppl 1():S125-30. PubMed ID: 10984082
    [Abstract] [Full Text] [Related]

  • 6. Hypercholesterolaemia due to familial defective apolipoprotein B-100 in two Australian families.
    Hosking JL, Bais R, Roach PD, Thomas DW.
    Med J Aust; 1991 Oct 21; 155(8):572-3. PubMed ID: 1943942
    [No Abstract] [Full Text] [Related]

  • 7. Familial defective apolipoprotein B-100 (R3500Q) in Northern Ireland.
    McClean E, Graham CA, Ward AJ, Young IS, Martin S, Nicholls DP.
    Br J Biomed Sci; 1999 Oct 21; 56(4):258-62. PubMed ID: 10795369
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Familial defective apolipoprotein-B is rare in hypercholesterolaemic South African Afrikaners, coloureds and Indians.
    Rubinsztein DC, Coetzee GA, van der Westhuyzen DR, Langenhoven E, Kotze MJ.
    S Afr Med J; 1995 May 21; 85(5):355-7. PubMed ID: 7638683
    [Abstract] [Full Text] [Related]

  • 13. Homozygous familial hypercholesterolemia due to APOB genetic variant with unusual clinical course.
    Chlebus K, Żarczyńska-Buchowiecka M, Pajkowski M, Chmara M, Tromp TR, Gruchała M.
    Kardiol Pol; 2021 May 21; 79(9):1030-1031. PubMed ID: 34125946
    [No Abstract] [Full Text] [Related]

  • 14. Rapid testing for three mutations causing familial defective apolipoprotein B100 in 562 patients with familial hypercholesterolaemia.
    Talmud PJ, Tamplin OJ, Heath K, Gaffney D, Day IN, Humphries SE.
    Atherosclerosis; 1996 Aug 23; 125(1):135-7. PubMed ID: 8831935
    [No Abstract] [Full Text] [Related]

  • 15. Familial defective apolipoprotein B-100: a mutation emerged in the mesolithic ancestors of Celtic peoples?
    Miserez AR, Muller PY.
    Atherosclerosis; 2000 Feb 23; 148(2):433-6. PubMed ID: 10657582
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of the LDL receptor in lipoprotein metabolism.
    Bilheimer DW, Grundy SM.
    Adv Exp Med Biol; 1987 Feb 23; 210():123-30. PubMed ID: 3296682
    [No Abstract] [Full Text] [Related]

  • 18. Experience with plasma-exchange in homozygous familial hypercholesterolaemia.
    Postiglione A, Thompson GR.
    Prog Clin Biol Res; 1985 Feb 23; 188():213-20. PubMed ID: 3903770
    [Abstract] [Full Text] [Related]

  • 19. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia.
    Innerarity TL, Mahley RW, Weisgraber KH, Bersot TP, Krauss RM, Vega GL, Grundy SM, Friedl W, Davignon J, McCarthy BJ.
    J Lipid Res; 1990 Aug 23; 31(8):1337-49. PubMed ID: 2280177
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.